医療用医薬品の錠剤の識別コード調査と一包化調剤された 持参薬の鑑別に及ぼす影響について

DOI Web Site

書誌事項

タイトル別名
  • Investigation of the Identification Codes Imprinted on Tablets, as well as of the Influence of These Codes on the Differentiation of Drugs Brought in by Patients, Which Have Been Dispensed as One-Dose Packages
  • イリョウヨウ イヤクヒン ノ ジョウザイ ノ シキベツ コード チョウサ ト イチ ホウカ チョウザイ サレタ ジサンヤク ノ カンベツ ニ オヨボス エイキョウ ニ ツイテ

この論文をさがす

抄録

Objective: The present study aimed to investigate the identification codes of tablets used in clinical practice, and to clarify the influence of these codes on the differentiation of drugs brought in by patients, and those that have been dispensed as one-dose packages at Tottori University Hospital.<br>Methods: We obtained the identification codes of tablets, which were released on the market before December 2013, based on their package inserts.  Concerning drugs without identification codes, we conducted a questionnaire survey involving companies releasing these drugs in order to clarify the reasons for the absence of these codes.  Among the drugs brought to the Hospital by patients who were hospitalized in 2013, we investigated the identification codes of tablets dispensed as one-dose packages, and the accuracy of the differentiation of these tablets.<br>Results: We investigated a total of 5,797 tablets. Among the tablets in which the identification codes imprinted on one side of these tablets were the same, the other side did not have codes for 65 tablets (28 pairs), and had different codes for 1,836 tablets (198 pairs).  A total of 244 tablets did not have identification codes.  The most common reason for releasing drugs without such codes was the cost.  Investigation of the drugs brought in by patients hospitalized revealed that some pharmacists mistook Grinolart®50 mg for Glucobay®50 mg due to them having the same code.<br>Conclusion: To prevent the misidentification of drugs brought in by patients, hospital pharmacists need to cooperate with other hospitals and health insurance pharmacies, and dispense drugs while regarding their distinguishability as of major importance.  In addition, to increase the distinguishability, identification codes need to be imprinted on both sides of tablets, and there is a need to avoid manufacturing drugs whose identification codes are the same.

収録刊行物

  • 医薬品情報学

    医薬品情報学 18 (2), 123-130, 2016

    一般社団法人　日本医薬品情報学会

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ